Please Wait
Applying Filters...
menu
    • menu
    Strides Pharma Science-PSE
    News
    Amgen's Rare Disease Drug Linked to Deaths with- liver injuries

    16 May 2026

    // REUTERS

    Candel Reports Long-Term Prostate Cancer Data Ahead of FDA Filing

    16 May 2026

    // ENDPOINTS

    Supreme Court Preserves Mail Access For Abortion Pill

    16 May 2026

    // ENDPOINTS

    DATA COMPILATION
    #PharmaFlow

    Beltapharm SPA

    Contact Supplier

    Website

    PEGS Boston Summit

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/prostaglandin-market-to-cross-us-1-27-bn-by-2035-liquidia-s-yutrepia-okayed-for-pulmonary-hypertension
    Left Arrow
    Right Arrow
    Related CompaniesRelated Companies

    About

    BELTAPHARM S.p.A. was started in 1982 by a team of entrepreneurs with experience in the pharmaceutical field. Its scope is the production by contract manufacturing of pharmaceuticals for human. These are produced in the commonest pharmaceutical forms, mainly as generics (ex galenics), for export outside Europe (Africa, Asia and Latin America). Beltapharm S.p.A is approved as third-party manufacturer by several Italian and European companies for the production of pharmaceuticals in liquid and semi-solid forms, with a particular emphasis on steroid-based products like: cream,ointments and gels, both for human and veterinary use.
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.